Wade J J
Dulwich Public Health Laboratory & Medical Microbiology, King's College School of Medicine & Dentistry, London, UK.
Eur J Clin Microbiol Infect Dis. 1997 Feb;16(2):113-9. doi: 10.1007/BF01709469.
Most of the characteristics that have ensured the success of enterococci as nosocomial pathogens were described early in this century. Enterococcus faecium and Enterococcus faecalis, the enterococci most frequently isolated from clinical material, differ fundamentally. The intrinsic antimicrobial resistance of Enterococcus faecium, supplemented by acquired resistance mechanisms, can generate a glycopeptide-multiply-resistant nosocomial pathogen that survives on hands and in the environment, and has the potential for intra-hospital and inter-hospital spread. The use of terms such as 'an enterococcus', 'faecal streptococci' and 'group D streptococci' have hindered, and still hinder, our understanding of a species rapidly emerging as the most problematic of nosocomial pathogens.
确保肠球菌作为医院病原体成功的大多数特性在本世纪初就已被描述。粪肠球菌和屎肠球菌是最常从临床材料中分离出的肠球菌，它们有根本区别。屎肠球菌的固有抗菌耐药性，再加上获得性耐药机制，可产生一种对糖肽多重耐药的医院病原体，该病原体可在手部和环境中存活，并有可能在医院内和医院间传播。使用诸如“一种肠球菌”、“粪链球菌”和“D组链球菌”等术语过去阻碍了、现在仍然阻碍着我们对一种迅速成为医院病原体中问题最大的物种的理解。
